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Abstract 
Recent data suggests nNOS mediates the NO-component of reflex cutaneous vasodilation 
with passive heat stress. Our hypothesis was nNOS, but not eNOS, inhibition would attenuate 
reflex cutaneous vasodilation during dynamic exercise. Protocol 1: subjects performed a VO2 
peak test on a supine cycle ergometer. Protocol 2: with experimental arm at heart level subjects 
cycled in supine posture at 60% VO2 peak to raise core temperature (Tc) 0.8-1.0°C (35-45 min). 
In protocol 2 subjects were equipped with 4 microdialysis fibers on the forearm and each 
randomly assigned as: 1) lactated Ringer’s (control); 2) 5mM NPLA (nNOS inhibition); 3) 
10mM L-NIO (eNOS inhibition); and 4) 20mM L-NAME (non- selective NOS inhibition). At 
the end of protocol 2 all sites were locally heated to 43°C and infused with SNP to elicit 
maximal dilation. Mean arterial pressure (MAP), skin blood flow via laser- Doppler flowmetry 
(LDF), and Tc via ingestible telemetric pill were measured; cutaneous vascular conductance 
(CVC) was calculated as LDF/MAP and normalized to maximum. In protocol 2 there was no 
significant difference between control (62±5 %CVCmax) and NPLA (61±6 %CVCmax). L-NIO 
(38±4 %CVCmax) and L-NAME (41±7 %CVCmax) significantly attenuated CVC compared to 
control and NPLA (p<0.001 all conditions). There was no difference between L-NIO and L- 
NAME. We conclude eNOS, not nNOS, contributes to reflex cutaneous vasodilation during 
dynamic exercise.  
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Chapter 1 - Introduction 
In humans, the primary autonomic response to an increase in core temperature is 
increased blood flow to the skin and sweating. The cutaneous vasodilation and sweat response to 
heat stress is mediated by two branches of the sympathetic nervous system: the adrenergic 
vasoconstrictor system and the cholinergic vasodilator system (23). The initial increase in skin 
blood flow in response to passive heating is achieved by withdrawal of tonic sympathetic 
vasoconstrictor tone (23), while further cutaneous vasodilation and instigation of sweating is 
achieved via activation of sympathetic cholinergic nerves (16).  
The sympathetic cholinergic active vasodilator nerves are responsible for the majority of 
vasodilation (28) through co-transmission with acetylcholine of an unknown substance (Figure 
1). The co-transmission theory suggests acetylcholine is responsible for the sweat response, 
while the unknown substance(s) are responsible for the vasodilation. The specific substance(s) 
and mechanism by which the vasodilation occurs and to what degree each contributes has been 
the subject of controversy and continuing research. Several vasodilator substances have been 
proposed in conjunction with the co-transmission theory including: substance P, vasoactive 
intestinal peptide (20) , H1 histamine receptor activation (55), and prostaglandins (36). In 
addition, nitric-oxide (NO) has been shown to directly contribute ~30-45% to cutaneous active 
vasodilation during passive heating (22, 25, 47). The source(s) of NO during passive heating are 
unclear, but recent data suggests neuronal NO synthase (nNOS) is the primary nitric-oxide 
synthase (NOS) isoform contributing to NO during passive heating (27, 29).  
During dynamic exercise, a large proportion of muscle mass is engaged and the most 
abundant byproduct of the muscle contraction and increased metabolism is heat. As a result, core 
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temperature (Tc) increases. As with passive heating, the increase in core temperature during 
dynamic exercise results in an increase in skin blood flow and sweating; however, these 
responses are delayed compared to passive heating. This rightward shift in the core temperature 
threshold for cutaneous vasodilation results from the competition between working skeletal 
muscle and the skin for cardiac output (15, 30). In addition, the initial skin blood flow response 
to dynamic exercise is adrenergic sympathetic vasoconstriction. Although several studies have 
documented an increase in skin blood flow during exercise and have studied modifiers of the 
skin blood flow response (e.g. changes in skin temperature), there have been no studies 
investigating mechanisms of cutaneous vasodilation during dynamic exercise. The underlying 
assumption has been the mechanisms are the same during passive heat stress. The purpose of this 
study was to investigate the mechanisms directly involved with cutaneous vasodilation due to 
endogenous heat stress. Specifically, we investigated the contribution of endothelial NO synthase 
(eNOS) and nNOS to the cutaneous vasodilation during dynamic exercise. We hypothesized 
nNOS, not eNOS, would contribute to reflex cutaneous vasodilation during dynamic exercise.  
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Chapter 2 - Literature Review 
The mechanisms through which humans vasodilate the cutaneous circulation for 
thermoregulation during passive whole body heating or dynamic exercise are complicated. In 
addition, there has been no research concentrating on the mechanisms of cutaneous vasodilation 
during dynamic exercise. The research surrounding cutaneous vasodilation has focused on the 
mechanisms responsible during passive heating. Several possible mechanisms have been 
identified for cutaneous vasodilation and include: Substance P (54), vasoactive intestinal peptide 
(20) , H1 histamine receptor activation (55), and prostaglandins (36). In addition, NO has been 
shown to directly contribute ~30-45% to cutaneous active vasodilation during passive heating 
(22, 25, 47). How and when these mechanisms are activated and the magnitude of the role they 
play in cutaneous vasodilation is still being studied but the research suggests there is no one 
substance or mechanism primarily responsible. Instead, the research suggests there is a redundant 
and complex system surrounding cutaneous vasodilation. 
The first section of this review will focus on the mechanisms of vasodilation during 
passive heating and the role of the sympathetic nervous system. Next, the mechanisms believed 
to be responsible for the observed response during passive heating will be discussed. The second 
section of this review will focus on the vasodilation response observed during dynamic exercise. 
Inasmuch as there have been no mechanistic studies during dynamic exercise, this second section 
will be brief.  
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 Skin Blood Flow Response to Passive Heating 
Theories surrounding the vasodilation process began with observations of vasoconstrictor 
and vasodilator nerves by Bernard in 1852 (2) and in 1858 (3), as well as Brown-Sequard’s work 
in 1852 (5). Research continues to study the human response to changes in temperature. Early 
experiments designed to study the effects of heat on blood flow were conducted by submerging a 
limb in warm water. These methods resulted in an increased blood flow in the limb not placed in 
warm water (13, 34), suggesting the increase in skin blood flow to limb heating is of reflex 
origin. When the same methods were used but sympathetic nerves were either blocked or cut, the 
blood flow response was abolished (1, 16, 17), providing evidence that sympathetic nerves were 
involved in the reflex increase in skin blood flow. These studies provided the first evidence for 
the role of the sympathetic nervous system in the response of increased limb blood flow during 
passive heating. Further studies revealed both the adrenergic vasoconstrictor system and the 
cholinergic systems have a role in the vasodilation (23). In addition,  it was subsequently found 
that the initial increase in skin blood flow in response to passive heating was achieved by 
withdrawal of the tonic sympathetic vasoconstrictor tone (23) while further cutaneous 
vasodilation and the instigation of sweating was achieved via activation of the sympathetic 
cholinergic nerves (16).  
Although evidence was provided for a cutaneous vasodilation mechanism mediated by 
the two branches of the sympathetic nervous system, the mechanisms involved in this process 
remained unknown. It remained unclear if acetylcholine was responsible for both the sweat 
response and increase in cutaneous vasodilation. To investigate the role of acetylcholine a 
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number of studies used atropine to block acetylcholine receptors. In these studies the sweat 
response was abolished while atropine delayed but did not affect the magnitude of the 
vasodilation (9, 11, 43). The co-transmission theory has been proposed to explain these results 
by suggesting acetylcholine is responsible for the sweat response while an unknown substance is 
responsible for the vasodilation (28). In order to establish the role of the cholinergic response to 
passive whole body heating Kellogg administered botulinum treatment to human skin (28). The 
treatment inhibited presynaptic release of cholinergic vesicles and transmitters and in turn 
cutaneous vasodilation and sweating responses were abolished. These observations, combined 
with previous observations showing muscarinic receptor blockade using atropine abolished only 
the sweat response (9, 11, 43, 44), led Kellogg and colleagues to conclude cutaneous 
vasodilation mechanisms were mediated by one or more unknown neurotransmitters (30). The 
specific substance and mechanism by which the vasodilation occurs and to what degree each 
may contribute has been the subject of controversy and continuing research. 
Several mechanisms have been presented in conjunction with the co-transmission theory 
in regards to the redundant thermoregulatory vasodilation response. These potential mechanisms 
include substance P, vasoactive intestinal peptide (20) , H1 histamine receptor activation (55), 
prostaglandins (36), and NO (22, 25, 47) (Figure 1). 
Several studies have shown NO directly contributes ~30-45% to cutaneous active 
vasodilation during passive whole body heating (22, 25, 47). During passive whole body heating 
in humans, if the cholinergic and adrenergic nerves are blocked, the vasodilation is only partially 
attenuated (31, 32, 42, 43, 50). The cause of the remaining vasodilation was hypothesized to be 
due to NO. This hypothesis was tested by Taylor and Bishop in the rabbit ear (51) where they 
showed the blockade of NO synthase eliminated the rise in blood flow during heating. This result 
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suggested NO may be responsible for the rise in blood flow seen in humans after the cholinergic 
and adrenergic systems had been blocked. However, a study by Dietz (8) demonstrated in 
humans, this is not the case. Dietz demonstrated the NO synthase blocker N5-
[imino(methylamino)methyl]-L-ornithine citrate (L-NMMA) did not decrease the rise in forearm 
blood flow or skin blood flow in humans. In their study, the L-NMMA was administered via an 
intra-arterial infusion. Dietz did not see a decrease in blood flow after L-NMMA was 
administered, as seen in the rabbit ear. Therefore, Dietz concluded NO did not play a significant 
role in increasing cutaneous blood flow during body heating in humans.  
Subsequently, Kellogg (24) and Shastry (48) independently presented data exhibiting the 
need for functional NO synthase in order to achieve full expression of active cutaneous 
vasodilation. Their studies offered evidence to refute observations of NO synthase blockade 
failing to reduce blood flow in humans where an active vasodilation is present (8) and 
independently confirmed the results of Taylor and Bishop’s study in the rabbit ear (51). 
 Skin Blood Flow Response to Dynamic Exercise 
During dynamic exercise, a large proportion of muscle mass is engaged and the most 
abundant byproduct of the muscle contraction and increased metabolism is heat. As a result, core 
temperature increases. As with passive heating, the increase in core temperature during dynamic 
exercise results in an increase in skin blood flow and sweating; however, these responses are 
delayed compared to passive heating. This rightward shift in the core temperature threshold for 
cutaneous vasodilation results from the competition between working skeletal muscle and the 
skin for cardiac output (15, 30). In addition, the initial skin blood flow response to dynamic 
exercise is vasoconstriction from the adrenergic sympathetic nervous system. Although several 
studies have documented an increase in skin blood flow during exercise (6, 7, 10, 38-41, 45, 49, 
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52) and have studied modifiers of the skin blood flow response (e.g. changes in skin 
temperature), there have been no studies investigating mechanisms of cutaneous vasodilation 
during dynamic exercise. The underlying assumption has been the mechanisms are the same as 
during passive heat stress. The lack of mechanistic studies investigating the increase in skin 
blood flow during dynamic exercise served as the basis for this thesis project. Specifically, the 
contribution of NO to the cutaneous vasodilation during dynamic exercise was investigated.  
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Chapter 3 - Methods 
 Ethical Approval 
Protocols utilized were approved by the Institutional Review Board at Kansas State 
University. Subjects were volunteers from the Kansas State University student population. An 
informed consent was reviewed and signed by each subject prior to participation in the study.  
 Subjects 
There were eight subjects, all men between the ages of 20 and 25 years. Prior to 
participation, all subjects filled out a health history form to ensure nonsmoking status, the 
absence of disease and a family history absent of cardiovascular disease. None of the subjects 
were taking any medications. All subjects were asked to refrain from caffeine, alcohol and 
strenuous exercise for 12 hours prior to each protocol. Each subject participated in two protocols: 
The first was a VO2peak test and the second, a prolonged bout of cycling. 
 Subject Monitoring 
Subjects were monitored with an electrocardiogram throughout the second protocol (S/5 
Light Monitor; Datex-Ohmeda, GE Healthcare; Madison, WI, USA). Blood pressure was 
monitored beat-by-beat via photoplethysmography (NexfinHD; BMEYE, Amsterdam, The 
Netherlands), which was verified via automated brachial auscultation (S/5 Light Monitor; Datex-
Ohmeda, GE Healthcare; Madison, WI, USA) every 5 minutes. Skin blood flow measurements 
were taken from the lateral aspect of the left forearm, while subjects were in the supine position 
with the experimental arm at heart level for the entire protocol. All experiments were performed 
in a thermoneutral laboratory. 
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Near the end of protocol two, local skin temperature was increased from 33°C to 43°C to 
induce maximal vasodilation utilizing local heating devices (PF5020 local heating units and 
PeriFlux 5020 Temperature Unit; Perimed; Jarfalla, Sweden). The local heating units used in the 
second protocol covered a 10mm area of the skin and allowed for temperature increases in 1°C 
increments. 
During protocol two, core temperature was measured via telemetric ingestible pill 
(CorTemp Data Recorder, CorTemp Temperature Sensor, Wireless Sensing Systems and Design, 
Palmetto, FL, USA) every minute.  
 Subject Instrumentation 
 Microdialysis Technique 
In protocol two, all subjects had four microdialysis fibers placed into the dermal layer of 
the skin of the left ventral forearm.  Microdialysis fibers were used to administer drugs to local 
areas of skin in the forearm. Drug sites were chosen at random. The administration of drugs was 
accomplished via the semi-permeable membrane found in each fiber, as seen in Figure 2. The 
membrane allowed for the diffusion of drugs from the fiber into the local area. The membranes 
of the microdialysis fibers were 10 mm in length with a 55-kDa molecular mass cutoff (CMA 31 
Linear Probe; CMA Microdialysis, Sweden). 
 Fibers were placed approximately 3-5 cm apart on the ventral surface of the left forearm 
in the absence of anesthetics; however, ice was used to numb the skin prior to placement (18). 
Fiber placement was accomplished by first threading a 23-gauge needle through the skin at each 
desired site of microdialysis placement. A microdialysis fiber was then threaded through the 
lumen of the needle, and the needle removed, leaving the membrane in place. To account for 
trauma, cutaneous blood flow was monitored via Laser-Doppler Flowmetry as described below 
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and allowed to return to resting values before the start of the protocol. During this time, all fibers 
were perfused with lactated Ringer’s solution at a rate of 4 μl/min.  
 Laser-Doppler Flowmetry 
Laser-Doppler Flowmetry (LDF) was used as an index of red blood cell (RBC) flux. 
Laser-Doppler Flowmetry measures the doppler shift of a laser as it is reflected off red blood 
cells moving through the skin. Laser-Doppler Flowmetry is a non-invasive method for obtaining 
a continuous index of RBC flow and has been shown to be a reliable method of determining skin 
blood flow without influence from blood flow in the underlying muscle (21, 46). 
The vasodilator response during dynamic exercise and local heating was observed at the 
site of each of the four microdialysis fibers. Local heating units were placed on the skin centered 
on each semi-permeable membrane. An integrated laser-Doppler probe, (Probe 413; Perimed; 
Jarfalla, Sweden) each with seven emitting and receiving probes, was placed at each 
microdialysis site directly over each semi-permeable membrane in the center of each local 
heating unit to estimate RBC flow directly over each microdialysis membrane site.  The 
placement and function of the microdialysis fiber and its membrane along with the LDF probe is 
shown in Figure 2. 
 
  
 Protocols 
 Protocol One: Determination of VO2Peak 
VO2peak was measured with the subjects cycling in the supine position, on a custom built 
stationary cycle ergometer. After a five minute unloaded warm up at 60 rpm, the workload was 
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increased 25 watts each minute until the subjects reached exhaustion. Subjects were instructed to 
maintain 60 rpm and were assisted via audio tone from an electronic metronome. Exhaustion was 
determined when the subject could no longer maintain 60rpm despite verbal encouragement.  
 
 Protocol Two: Dynamic Exercise-Induced Heat Stress/ Prolonged Cycling 
Heat stress was accomplished by having the subjects cycle in the supine position, on a 
stationary bicycle ergometer, at a workload sufficient to elicit and maintain 60% VO2peak. 
Subjects were instructed to maintain 60rpm and were assisted via audio tone from an electronic 
metronome. Cycling was stopped when core temperature rose 0.8-1.0°C. It took subjects a range 
of 35-45 min to reach the desired rise in core temperature.   
 Drugs Administered 
 Nitric Oxide Synthase Inhibition 
A 20 mM dose of the L-arginine analog N
G
-nitro-L-arginine methyl ester (L-NAME; 
Tocris Bioscience; Minneapolis, MN, USA), dissolved in lactated Ringer’s solution was used to 
inhibit NO synthase. This concentration has been shown to inhibit NO synthase in human skin 
(19, 56). A 5mM dose of N-Propyl-L-Arginine (NPLA; Tocris Bioscience; Minneapolis, MN, 
USA), dissolved in lactated Ringer’s solution was used to inhibit neuronal nitric oxide synthase 
(nNOS). This concentration has been shown to inhibit nNOS in human skin (29). A 10mM dose 
of N5-(1-iminoethyl)-L-Ornithine dihydrochloride (L-NIO; Tocris Bioscience; Minneapolis, 
MN, USA), dissolved in lactated Ringer’s solution was used to inhibit endothelial nitric oxide 
synthase (eNOS). Pilot work in our laboratory determined this concentration effectively inhibits 
the NO-dependent vasodilation to local heating of the skin. All drugs were administered 
simultaneously at the start of exercise via microdialysis at a rate of 4μl/min. 
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 Nitric Oxide Donor 
Maximal skin blood flow was elicited after cycling at all microdialysis sites, once the 
subject was at rest, via infusion of 28 mM sodium nitroprusside (SNP) at a rate of 4μl/min and 
application of local heat via heating units  to a skin temperature of 43ºC. This concentration of 
SNP has been previously shown to elicit maximal vasodilation in human skin (26, 37). 
 Data Collection and Analysis 
Data were digitized and stored at 100 Hz on a personal computer. Data were analyzed 
offline using signal-processing software (Windaq; Dataq Instruments, Akron, OH, USA). Skin 
blood flow data were converted to cutaneous vascular conductance (CVC), calculated as the ratio 
of skin blood flow to mean arterial pressure (RBC flux/mean arterial pressure). Cutaneous 
vascular conductance data were expressed as a percentage of maximal vasodilation (%CVCmax) 
via SNP infusion and local heating to 43°C. 
All data were analyzed using a one way repeated measures ANOVA and Tukey’s post 
hoc analysis was used to determine where significant differences occurred. All statistical 
analyses were performed using SigmaStat 3.5 (Systat Software; Point Richmond, CA, USA). All 
values are presented as mean ± SEM, and P-values < 0.05 were considered to be significant. 
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Chapter 4 - Results 
Subject characteristics are described in Table 1.  On average, subjects cycled at 53% of 
their peak power from protocol 1 in order to elicit the desired 60% VO2peak during protocol 2. 
The group mean hemodynamic data at rest and during exercise at an increase of core temperature 
of 0.8ºC is summarized in Table 2. Compared to baseline, there was a significant increase in 
heart rate, cardiac output and core temperature (p<0.001) for all subjects. Compared to baseline, 
there was a significant increase in systolic blood pressure, diastolic blood pressure and systemic 
arterial pressure (p<0.05) for all subjects.  
The group mean data for the increase in %CVCmax elicited following a 0.8ºC increase at 
each treatment site are summarized in Figure 3. There was no significant difference between 
control (65 ± 1 %CVCmax) and NPLA (64 ± 6 %CVCmax). L-NIO (44 ± 3 %CVCmax) and L-
NAME (39 ± 2 %CVCmax) significantly attenuated CVC compared to control and NPLA 
(p<0.001 all conditions). There was no difference between L-NIO and L- NAME responses.  
The percent contribution of eNOS and nNOS to the increase in %CVCmax is shown in 
Figure 4. The contribution of eNOS (32 ± 4 %CVCmax) was significantly greater than the 
contribution of nNOS (3 ± 7 %CVCmax) (p<0.05).  
Figure 5 shows the increase in %CVCmax as a function of increasing core temperature 
from baseline to the end of the exercise at 0.1ºC increments. The increase in %CVCmax occurred 
with an increase in core temperature of 0.4 ºC at all treatment sites.  
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Chapter 5 - Discussion 
This study is the first to investigate the mechanisms of reflex cutaneous vasodilation 
during dynamic exercise in humans. The main finding of this study was that eNOS not nNOS 
contributed to reflex cutaneous vasodilation during dynamic exercise. This finding was 
inconsistent with our original hypothesis that nNOS but not eNOS inhibition would attenuate 
reflex cutaneous vasodilation during dynamic exercise. Our finding was substantiated by 
decreased skin blood flow during dynamic exercise at microdialysis sites where an eNOS and 
non selective NOS specific antagonist where present. These data suggest eNOS is the primary 
NOS enzyme responsible for the NO-component of reflex cutaneous vasodilation during 
dynamic exercise as the control site was not significantly different from the nNOS (NPLA) 
antagonist site. In as much as the eNOS (L-NIO) site was not significantly different from the non 
selective NOS antagonist site (L-NAME) these data further suggest a role for eNOS but not 
nNOS during endogenous heat stress due to dynamic exercise. 
The data from this study suggest NO directly contributes ~30% to the increase in skin 
blood flow during dynamic exercise, which is similar to several studies that have shown NO 
directly contributes ~30-45% to cutaneous active vasodilation during passive whole body heating 
(22, 25, 47). Although precise mechanisms underlying the NO-component of cutaneous active 
vasodilation remains vague, Kellogg et al. (29) recently demonstrated nNOS is the primary NOS 
isoform activated during passive whole body heating (29). These data from passive heat stress 
are contrary to our current findings. 
Several studies have clearly shown a robust cutaneous vasodilation during exercise (6, 7, 
10, 38-41, 49, 52). However, mechanistic data underlying this cutaneous vasodilation is lacking. 
To date, only one study by Blair et al. in 1961 (4) has provided evidence that the increase in skin 
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blood flow during exercise may be of reflex origin. It has often been assumed mechanisms are 
similar during dynamic exercise and passive whole body heating. However, data from our study 
suggest these mechanisms may differ depending on the means by which hyperthermia is induced.  
Our data clearly suggest eNOS is responsible for the NO-component of cutaneous 
vasodilation during dynamic exercise; however, it is unclear what is responsible for activating 
eNOS. There are at least three possible mechanisms for this observed response including 
cutaneous heat load, shear stress, and heat shock proteins (HSP) (Figure 6). The difference in the 
application of the heat stress resulting in a different cutaneous heat load may be responsible for 
the difference in nNOS and eNOS activation between passive and active heating protocols. 
During passive heating, skin temperature is elevated (cutaneous heat load) whereas during 
exercise, evaporation of sweat cools the skin. Neuronal nitric oxide has been observed to be 
responsible for the cutaneous vasodilation response during passive heating protocols in which the 
subject’s skin temperature is elevated, which differs from our study where subjects’ sweat 
evaporated and cooled the skin. 
Shear stress may also play a role in the response seen in our experiment. Shear stress is 
thought to be activated by chemical or physical stimuli which lead to a release of vasoactive 
substances in turn allowing for an increase in flow (14). The increase in flow increases the 
friction between a fluid and a stable surface, in this case the blood and endothelium respectively, 
resulting in an elevated wall shear stress. Vasoactive substances have been shown in vitro to be 
released in response to any increase in wall shear stress by way of stimulating the endothelial 
cells (6, 7, 10, 38-41, 49). As vessel diameter is inversely associated with wall shear stress (14) 
the potential for the cutaneous vasculature to react to small changes increases substantially.  
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Heat shock proteins are another possible mechanism responsible for the activation of 
eNOS during dynamic exercise. There are many HSPs in the human body but HSP90 in 
particular has been observed to increase eNOS activity (12). In addition, HSP90 has been shown 
to be activated by fluid shear stress (12). An experiment which exposed endothelial cells to fluid 
shear stress resulted in an increased association of eNOS and HSP90 (12). A possible cause for 
the interaction between these proteins may be an enhanced molecular attraction activated by 
fluid shear stress (12). According to Garcia-Cardena et al. (12) eNOS activation may result from 
HSP90 inducing a conformational change in eNOS by acting as an allosteric modulator or by 
stabilizing the dimeric form. To examine the dependence of eNOS activation by HSP90, an 
HSP90 specific inhibitor was used and the observed decrease in maximal response was similar to 
NOS inhibitors such as L-NAME, suggesting HSP90 may be necessary for NO release. Data 
further suggest HSPs may be cell-type specific (33) such that HSP90 may only bind to eNOS and 
not nNOS in addition to having a specific binding site on eNOS.  
  
 Limitations 
There are four possible limitations to our study, which should be addressed. First, most 
human thermoregulation studies have been performed in the forearm and therefore the 
mechanisms controlling the cutaneous vasculature may vary according to anatomical location. 
Second, the mechanisms involved with cutaneous active vasodilation during dynamic exercise 
remain unresolved. In an experiment conducted by Blair and colleagues (4), in which the 
cutaneous nerves to the forearm were blocked, results suggested the vasodilation response during 
leg exercise was due to an active vasodilator mechanism; however, there have been no 
subsequent studies designed to elucidate potential mechanisms. Third, training has been shown 
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to have an effect on eNOS expression (35, 53) and our subjects were all at least moderately 
trained individuals. The data from this study show eNOS, not nNOS, contributes to reflex 
cutaneous vasodilation during dynamic exercise. Fourth, this is the first in vivo human study to 
use L-NIO to specifically inhibit eNOS. Although pilot work in our laboratory demonstrated 
10mM L-NIO maximally inhibited the skin blood flow response to local heating, it is possible 
higher concentrations would attenuate the response further. 
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Figure 1: Schematic of the Co-Transmission theory. 
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Figure 2: Schematic drawing of the microdialysis technique and placement of a laser-
Doppler flow probe. 
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Figure 3: Group mean (± SEM) CVC data from protocol 2. Data are from a 0.8ºC increase in 
core temperature during exercise. NPLA had no significant effect on mean CVC. However, L-
NAME and L-NIO significantly reduced CVC compared to control and NPLA. L-NAME and L-
NIO were not significantly different from the other.   
* p<0.001 vs. Control and NPLA. 
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Figure 4: Group mean (± SEM) CVC data from protocol 2 percent contribution of eNOS 
and nNOS. The contribution of eNOS to the increase in CVC during exercise was significantly 
greater than the contribution of nNOS. 
* p<0.01 vs. eNOS. 
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Figure 5: Mean skin blood flow tracing for all treatment sites. The increase in %CVCmax 
occurred with an increase in core temperature of 0.4 ºC at all treatment sites. The increase in 
%CVCmax was significantly less for L-NAME and L-NIO sites * p<0.05 vs. baseline (ΔTc = 0ºC) 
for all sites vs. Control and NPLA sites. Data are means ± SEM. 
# p<0.01 vs. Control and NPLA. 
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Figure 6: Schematic of proposed mechanisms responsible for CVC observations during 
dynamic exercise.  
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Age 
(Year) 
Height 
(cm) 
Weight 
(kg) 
Absolute VO2 
(L/min) 
Relative VO2 
(ml/kg/min) 
Peak Power 
(Watt) 
Cycling Power 
(Watt) 
22 ± 1 177 ± 5 78 ± 13 3.51 ± 0.59 44.87 ± 9.52 278 ± 41 147 ± 34 
 
Table 1: Subject characteristics. Values are mean ± SD. 
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HEMODYNAMIC DATA 
       
 
SBP DBP SAP HR  CO Tc 
  (mmHg) (mmHg) (mmHg) (beat/min) (L/min) (°C) 
       Baseline 112 ± 2 64 ± 1 80 ± 4 58 ± 4 7 ± 1 36.51 ± 0.3 
       
       Exercise 153 ± 11* 70 ± 2* 99 ± 2* 145 ± 6 # 17 ± 0.4 # 37.32 ± 0.4 # 
              
* P < 0.05 vs. Baseline 
# P < 0.001 vs. Baseline 
 
Table 2: Group mean hemodynamic data for baseline and exercise. Compared to baseline, 
there was a significant increase in heart rate (HR), cardiac output (CO) and core temperature (Tc) 
(p<0.001) for all subjects. Compared to baseline, there was a significant increase in systolic 
blood pressure (SBP), diastolic blood pressure and systemic arterial pressure (SAP) (p<0.05) for 
all subjects. 
